dizzy after semaglutide shot The Risk of Vestibular Disorders with and Tirzepatide: Findings from a Large Real-World Cohort 9 Hidden Risks of Ozempic

An in vitro experimental model for analysis of central control of sympathetic nerve activity

Even where it falls into a grey area legally, the safety risks from unverified sources are significant

For some, the dual-agonist mechanism of Mounjaro provides the perfect balance of efficacy and tolerability, while others may find the single-agonist Wegovy 7.2mg dose, introduced on January 12, 2026, more suitable for their specific metabolic architecture

GLP-1RAs are generally recommended for patients with T2D whose glycated haemoglobin (HbA 1c ) is above target despite diet, exercise and existing glucose-lowering medication, and GLP-1RAs with proven cardiovascular benefit are also recommended in patients with T2D at elevated cardiovascular risk, regardless of HbA 1c [5, 6]

Drugs require specialist prescription